Doctors tend to ignore living wills
A small US study shows that nearly two-thirds of doctors would not follow instructions in living wills because of pressure from family members or because the prognosis for the patient was hopeful. Bioethics experts reacted to the article in the Archives of Internal Medicine with weary agreement. “There have been many studies over the course of the last decade which suggest that advance directives, especially living wills, are not particularly helpful, says Alan Meisel, of the University of Pittsburgh. And Howard Brody, of Michigan State University, says, “There are two obvious reasons why a doctor might not follow an advance directive. Reason one is that the doctor is a jerk and is practicing unethical medicine. The second reason is that [the] advance directive is unfollowable… People say things like ‘no heroics’. What does that mean? What’s heroic and isn’t heroic?”
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...